<DOC>
	<DOCNO>NCT02578771</DOCNO>
	<brief_summary>ZuraPrep evaluate efficacy preoperative skin preparation solution demonstrate immediate persistent antimicrobial property . At least 72 subject randomize utilizing bilateral application abdomen groin . ZuraPrep active product reference positive control compare ; ZuraPrep non-active negative control compare . Each subject receive two planned treatment , one leave side body one right . Study duration subject - 3 4 week .</brief_summary>
	<brief_title>Pilot Clinical Evaluation Characterize Vivo Effects Topically Applied ZuraPrep &amp; ZuraPrep Vehicle</brief_title>
	<detailed_description>The single investigational test article , ZuraPrep solution evaluate efficacy preoperative skin preparation solution demonstrate immediate persistent antimicrobial property . At least 72 subject randomize utilizing bilateral application abdomen groin . The primary objective study characterize vivo effect ZuraPrep test article compare positive reference control ChloraPrep , well evaluate ZuraPrep test vehicle negative control , Saline , use newly propose sampling interval . This randomized , paired-comparisons design subject receive two plan treatment , one leave side body one right . Treatments evaluate 30 second , 10 minute 6 hour sample interval compare baseline . Status calculate separately abdomen groin side body . Study duration subject - 3 4 week .</detailed_description>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<criteria>Healthy male female volunteer , 18 year age old . Are good general health . Have skin within 6 inch test site free tattoo , dermatosis , abrasion , cut , lesion skin disorder . Cooperative willing follow Subject Instructions . Cooperative willing sign Consent Form HIPAA Authorization Form . Have acceptable Screening Day baseline count ( CFU/cm2 ) . Topical systemic antimicrobial exposure within 14 day prior Screening Day . Restrictions include , limited antimicrobial soap , antiperspirants/deodorants , shampoo , lotion , perfume , shave , cologne , topical systemic antibiotic . Swimming chemically treat pool bath hot tub , spa whirlpool within 14 day prior Screening Day . Use tan bed , hot wax , depilatory , include shaving ( applicable test area ) within 14 day prior Screening Day . Contact solvent , acid , base , fabric softenertreated clothing household chemical applicable test area within 14 day prior Screening Day . Subjects history sensitivity natural rubber latex , adhesive skin product ( e.g. , BandAids , medical tape ) , isopropyl alcohol , citric acid , methylene blue , methylparaben , propylparaben , chlorhexidine gluconate product . Subjects history skin allergy . Subjects history skin cancer within 6 inch applicable test area . Subjects pregnant , attempt pregnancy nursing . For female childbearing potential ( &lt; 60 year age ) , urine pregnancy test perform prior treatment Treatment Day . Subjects shower bath within 72 hour Screening Day Treatment Day ( sponge bath may take , however , low abdomen upper thigh region must avoid ) . Subjects receive irritation score 1 individual skin condition prior Screening Day baseline Treatment Day baseline sample collection . Participation another clinical trial 30 day prior Test Day study ( treatment test material study ) , currently enrol another clinical trial , previously participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>